These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9168850)

  • 1. Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma.
    Mahajan P; Okamoto LJ; Schaberg A; Kellerman D; Schoenwetter WF
    J Asthma; 1997; 34(3):227-34. PubMed ID: 9168850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids.
    Okamoto LJ; Noonan M; DeBoisblanc BP; Kellerman DJ
    Ann Allergy Asthma Immunol; 1996 May; 76(5):455-61. PubMed ID: 8630720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma.
    Wasserman SI; Gross GN; Schoenwetter WF; Munk ZM; Kral KM; Schaberg A; Kellerman DJ
    J Asthma; 1996; 33(4):265-74. PubMed ID: 8707781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma.
    Pearlman DS; Noonan MJ; Tashkin DP; Goldstein MF; Hamedani AG; Kellerman DJ; Schaberg A
    Ann Allergy Asthma Immunol; 1997 Apr; 78(4):356-62. PubMed ID: 9109702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
    J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluticasone propionate aerosol: efficacy in patients with mild to moderate asthma. Fluticasone Propionate Asthma Study Group.
    Sheffer AL; LaForce C; Chervinsky P; Pearlman D; Schaberg A
    J Fam Pract; 1996 Apr; 42(4):369-75. PubMed ID: 8627205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: a randomized clinical trial.
    Busse W; Raphael GD; Galant S; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
    J Allergy Clin Immunol; 2001 Mar; 107(3):461-8. PubMed ID: 11240946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma.
    Ostrom NK; Decotiis BA; Lincourt WR; Edwards LD; Hanson KM; Carranza Rosenzweig JR; Crim C
    J Pediatr; 2005 Aug; 147(2):213-20. PubMed ID: 16126052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
    Kerwin EM; Nathan RA; Meltzer EO; Ortega HG; Yancey SW; Schoaf L; Dorinsky PM
    Respir Med; 2008 Apr; 102(4):495-504. PubMed ID: 18206361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study on the clinical equivalence and patient preference of fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler or the Diskhaler inhaler in adult asthmatic patients.
    Pieters WR; Stallaert RA; Prins J; Greefhorst AP; Bosman HG; van Uffelen R; Schreurs AJ; van Helmond JL; Janssen PG
    J Asthma; 1998; 35(4):337-45. PubMed ID: 9669827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents.
    Mahajan P; Pearlman D; Okamoto L
    J Allergy Clin Immunol; 1998 Jul; 102(1):19-23. PubMed ID: 9679843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.
    Noonan M; Chervinsky P; Busse WW; Weisberg SC; Pinnas J; de Boisblanc BP; Boltansky H; Pearlman D; Repsher L; Kellerman D
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1467-73. PubMed ID: 7582278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma.
    Rutherford C; Mills R; Gibson PG; Price MJ
    Respirology; 2003 Sep; 8(3):371-5. PubMed ID: 12911833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time.
    Faul JL; Leonard CT; Burke CM; Tormey VJ; Poulter LW
    Thorax; 1998 Sep; 53(9):753-61. PubMed ID: 10319057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an intranasal corticosteroid on exercise induced bronchoconstriction in asthmatic children.
    Kersten ET; van Leeuwen JC; Brand PL; Duiverman EJ; de Jongh FH; Thio BJ; Driessen JM
    Pediatr Pulmonol; 2012 Jan; 47(1):27-35. PubMed ID: 22170807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term treatment with a low dose of inhaled fluticasone propionate decreases the number of CD1a+ dendritic cells in asthmatic airways.
    Bocchino V; Bertorelli G; Zhuo X; Grima P; Di Comite V; Damia R; Chetta A; Del Donno M; Foresi A; Casalini A; Testi R; Olivieri D
    Pulm Pharmacol Ther; 1997; 10(5-6):253-9. PubMed ID: 9778488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study.
    van Grunsven PM; van Schayck CP; van Deuveren M; van Herwaarden CL; Akkermans RP; van Weel C
    J Asthma; 2000 May; 37(3):225-34. PubMed ID: 10831147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.